fluconazole has been researched along with Pulmonary Aspergillosis in 6 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Pulmonary Aspergillosis: Infections of the respiratory tract with fungi of the genus ASPERGILLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of a patient with hairy cell leukemia and pulmonary aspergillosis who developed a cycotic pulmonary artery aneurysm despite prolonged antifungal therapy." | 2.46 | Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature. ( Erasmus, J; Mattiuzzi, GN; Sever, M; Verstovsek, S, 2010) |
| "Despite advancements in diagnosing and treating invasive pulmonary aspergillosis (IPA), there is limited knowledge of real-world treatment pathways and medication switches." | 1.91 | Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study. ( Chastain, DB; Henao-MartÃnez, AF; Thompson, GR, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Erami, M | 1 |
| Hashemi, SJ | 1 |
| Raiesi, O | 1 |
| Fattahi, M | 1 |
| Getso, MI | 1 |
| Momen-Heravi, M | 1 |
| Daie Ghazvini, R | 1 |
| Khodavaisy, S | 1 |
| Parviz, S | 1 |
| Mehri, N | 1 |
| Babaei, M | 1 |
| Henao-MartÃnez, AF | 1 |
| Chastain, DB | 1 |
| Thompson, GR | 1 |
| Makino, Y | 1 |
| Nishiyama, O | 1 |
| Sano, H | 1 |
| Iwanaga, T | 1 |
| Higashimoto, Y | 1 |
| Kume, H | 1 |
| Tohda, Y | 1 |
| Lim, SY | 1 |
| Kano, R | 1 |
| Ooya, K | 1 |
| Kimura, S | 1 |
| Yanai, T | 1 |
| Hasegawa, A | 1 |
| Kamata, H | 1 |
| Chen, L | 1 |
| He, ZY | 1 |
| He, SM | 1 |
| Zhang, L | 1 |
| Huang, B | 1 |
| Tu, YY | 1 |
| Zhang, HX | 1 |
| Jiang, YK | 1 |
| Li, YZ | 1 |
| Sever, M | 1 |
| Verstovsek, S | 1 |
| Erasmus, J | 1 |
| Mattiuzzi, GN | 1 |
1 review available for fluconazole and Pulmonary Aspergillosis
| Article | Year |
|---|---|
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; An | 2010 |
5 other studies available for fluconazole and Pulmonary Aspergillosis
| Article | Year |
|---|---|
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Fe | 2023 |
Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Pulmonary A | 2023 |
Cavitary pulmonary cryptococcosis with an Aspergillus fungus ball.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Bronchos | 2014 |
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistanc | 2016 |
[A case report of severe hepatitis patient complicated with hemo-disseminated lung aspergillosis].
Topics: Adult; Amphotericin B; Antifungal Agents; Fluconazole; Glucocorticoids; Hepatitis B, Chronic; Humans | 2009 |